论文信息 - Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study - 字舞流文

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study

P. Sonneveld | P. Moreau | T. Facon | J. Vermeulen | C. D. de Boer | F. Offner | L. Garderet | F. Kuhnowski | M. Roussel | A. Stoppa | M. Tiab | K. Belhadj | C. Hulin | N. V. D. van de Donk | D. Caillot | L. Benboubker | J. Lambert | K. Jie | B. Kolb | L. Pei | M. Westerman | T. Kampfenkel | V. Vanquickelberghe